SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Top 10 Most Recent Blog Posts
Investment Tips for May 2024: Navigating the Financial Landscape
Category: Investing Total Views: 164By : Editor Updated: 05-04-2024
Personal Finance for Dummies 2024: A Comprehensive Guide to Managing Your Money
Category: Personal Finance Total Views: 118By : Editor Updated: 05-04-2024
Penny Stocks Under 10 Cents to Watch as of May 4, 2024
Category: Stocks Total Views: 141By : Editor Updated: 05-04-2024
Navigating the Market's Murky Waters: What to Watch in the Upcoming Week
Category: Markets Total Views: 124By : Editor Updated: 05-04-2024
Safe & Green Holdings Corp. (SGBX): A Comprehensive Analysis
Category: Stocks Total Views: 209By : Editor Updated: 05-03-2024
Beneficient (BENF): A Comprehensive Analysis Amidst a Stock Surge
Category: Stocks Total Views: 272By : Editor Updated: 05-03-2024
Wall Street Win: Surprise Surge Despite Economy - May 3, 2024
Category: Markets Total Views: 187By : Editor Updated: 05-03-2024
Understanding the Economic Factors Impacting Gas Prices
Category: Economy Total Views: 226By : Editor Updated: 05-03-2024
This Week's Stock Market Standouts: Top Performing Sectors
Category: Markets Total Views: 206By : Editor Updated: 05-03-2024
Top 25 Most Active Stocks by Percentage Gains for May 3, 2024
Category: Stocks Total Views: 220By : Editor Updated: 05-03-2024